“We combined cell biology, molecular biology, and pharmacological approaches to unravel a novel molecular pathway by which NAD+-boosting agent nicotinamide mononucleotide (NMN) regulates MSR in AD models.”
Key Points: NMN and NR provided several benefits in mice with FRDA and highlighted key differences between the two treatments: NMN more effectively restored NAD+ levels in the heart than...
Key Points Treatment with NMN showed several benefits for mice with AD: Enhanced cognition and memory Reduced neuronal injury Promoted clearance of abnormal tau protein Activated autophagy Enhanced antioxidant defense...
Key Points: Berberine supplementation displayed therapeutic benefits for managing Parkinson’s disease symptoms: Improved motor function and coordination Reduced oxidative stress and enhanced antioxidant defenses Restored mitochondrial function Decreased neuroinflammation and...
EGCG showed several benefits in mice with damaged neurons: Reduced anxiety-like behaviors and motor impairment Reduced degeneration of key brain cells controlling movement Lowered accumulation of harmful proteins linked to...
"Compared to traditional routes, the nasal administration of drugs can direct the rapid CNS absorption to brain tissues, thereby circumventing the hepatic first-pass metabolism and gastric degradation and allowing fast...
This study evaluated the safety and effects of high-dose (3,000 mg) Nicotinamide Riboside (NR) supplementation in patients with Parkinson’s Disease (PD).